70 Comments

"Yet the use of this evidence can never be as algorithmic as guidelines or quality measures or news stories make it seem." That statement is the essence of your message! There are so many applications to your message - it could be at the very least a book.

We try to teach students, that guidelines and algorhithms are not mandates, but must be adapted to the needs of the patient, family, and individual situation. Government mandates are even worse! Doctors must have the freedom to make judgements in concert with the patient. There will never be one size fits all in medicine.

Expand full comment

Wonderful piece. I appreciated the examples from other areas of medicine as well.

Expand full comment

I really liked your conclusion. No patient is the same as the "normal" patient. The clinician's job is to translate results as it relates to your current patient. So many people, especially the government, believe that you can tell how the patient will react to a treatment just by what the computer tells you. This is not true. Every patient is different, and a robot should never replace a clinician in the analysis of your patient.

Expand full comment

interesting, thank you.

p.s. note extraneous word in; They were young (age 64), mostly male, non-obese, patients who **were** could tolerate medical therapy of heart failure.

Expand full comment

And yet our Government spent 1.6 billion on Paxlovid and still advocating its use.

Expand full comment

If we can disregard drug trials because different people might react differently, we might as well not do drug trials at all. Each person is uniquely different from all other people in many different ways . The only way we can be investigate whether a drug will work on a given individual is to do a trial with many people who are identical to the person we want to use the drug on. This is impossible. Drug trials with a large number of subjects, all different from one another, can only tell us if the drug works on a population of subjects. It has public health significance but not necessarily relevant to any single individual. If we can't accept this limitation, then we should. just abandon all drug trials rather than conduct them and later point out their obvious uncertain relevance to any given individual.

Expand full comment

Great article and discussion -thank you Dr. John.

I'm a tech nerd, with no medical/science training, but have a curious mind and a love for data.

Seems like comprehensive RCT's are almost impossible to do with the type of confidence we'd hope for.

Humans are unique in their DNA, their range of physical conditions, etc....but what strikes me as a tough thing to factor in is the consideration of the patient's current pharma and med treatments.

Again, I'm not a practitioner, but trying to understand the interaction(s) of various pharma combinations, in a wide range of human condition seems like a daunting task.

Accepting this, RCTs must be done, but their conclusiveness will not be as strong as we'd like. That's why I think intelligent patient + intelligent holistically oriented medical professional are required. Need both to provide the best assessment and treatment approach. Industrial medicine does not promote this.

Also, the COVID has made me aware that there are multiple dimensions to good medical practice. Patient treatments, public health, socioeconomics, cultural consideration all must be considered.

In COVID, extreme "locking down" might have saved some lives, but the knock-on negative impacts would have been worse (IMHO). We need a holistic approach when dealing with big issues like this.

Expand full comment
Aug 3, 2022·edited Aug 3, 2022

The nurses, doctors, OTs, PTs, and research scientists in my family (two who also have their MPH) appreciate those like yourself willing to opine and provoke critical thinking and debate regarding medical practice and public health policy/actions. We recognize the complexities and nuances of providing best practice medicine, but we try our best to “check” any arrogance and bias during our debates. We often disagree on EBM interpretations and extrapolations as well as public health decisions. We all agree that trust in public health institutions and regulatory agencies have plummeted and with good reason.

Expand full comment

Nefarious is always a little difficult to prove but quite often the enrollment criteria for a trial can indicate intention. For example did Pfizer not enroll vaccinated patients due to availability or were they concerned with performance in this population?

Expand full comment

This article is spot on. Look at the “troponin” develop in very specific set of patients and circumstances and now drawn on everyone. How many people has a false troponin lead to procedures and complications. The “d-dimer” how much damage has that done when released broadly. PFO……we see studies looking for that in 88 year old patients……so sad how things that may help a few folks, when released get generalized and weaponized against patients, providers i guess in mainly the fear of “not doing enough”

Expand full comment

Brilliant! Absolutely brilliant - the right tone and pitch to share with my family and friends to awaken curiosity. Thank you 😊🙏

Expand full comment

never stop learning, (now at the age of 77)

Expand full comment

Again underscores the importance of evidence based practice and practitioners.

Expand full comment

This article only continues to confirm my working theory that the widespread failure of paxlovid is entirely the result of interaction with vaccine-induced damage to the immune system (antigenic fixation and likely other injuries as well).

The phenomenon of "paxlovid rebound" is occurring all over the place because viral counts are brought low by paxlovid's enzyme inhibition, but there is little effective immune response during this time- there is no "knockout punch" during the window of opportunity the drug allegedly produces.

Furthermore, I suspect they knew this was likely by the time of the trials- vaccine failure was already visible to insiders if not to the public- and made sure a non-representative sample gave them the results they wanted.

I'm glad my unvaccinated ass hasn't had to experience any of this firsthand.

And it remains my deepest wish that the liars, frauds, and murderers in this worldwide crime spree pay and pay dearly for what they have done.

Expand full comment

This, to me, is not a good thing. It is partly why we have so much experimental polypharmacy. Doctors prescribe all of these meds I would suppose from studies that do not reflect the real world. Patients need the real world results, not profiteering theatrics. The research nurses and pharmacists should know about safety signals and contraindications within the trials. And doctors should get all of the data. The pfizer vaccine data dump at PHMPT.ORG is a perfect example of important data withheld from doctors, that should never be allowed. And yet here we are...

Expand full comment

like with the statins.

the chance of benefit is near to negligible, the risk of side effects is 100%.

Expand full comment